Quadria Capital: Asia’s Top Private Equity Firm Driving Healthcare Innovation

Image
  In a region teeming with economic growth and healthcare challenges, private equity in Asia has emerged as a powerful force for transformation—and Quadria Capital is leading that charge. Rather than simply injecting funds into the system, this independent private equity firm is rewriting the rules of healthcare investment with a strategy that prioritizes growth, innovation, and long-term social impact.   As one of the largest private equity firms focused exclusively on the Asia-Pacific healthcare sector, Quadria Capital is quietly yet profoundly reshaping how healthcare is delivered across Asia . But what makes them different from the typical investor? It’s not just about capital— it's about commitment, capability, and a clear vision for sustainable impact.   A Purpose-Driven Investment Strategy   Quadria Capital sees the Asia as a critical market where the right investments can make a disproportionate difference. From multi-specialty hospitals and pharmaceut...

Impact of COVID-19 Outbreak On Private Equity Firms


As the COVID-19 outbreak continues to impact the business all across the world, the funding by private equity firms in India is going downward. There is a significant decrease in private equity funding in India owning to coronavirus outbreak as investors have put a hold on their plans of funding due to fear of economic fallout in combating the pandemic.

covid-19


According to a recent report the amount of private equity investment has been declining over the last few months and it has reached 40.3% in March. Further, foreign investors are also pulling back their money. March month has been very sluggish due to pandemic with private equity investment seeing a drop of more than 50% compared to February 2020.  Owning to the widespread uncertainty and economic slowdown due to the spread of COVID-19 and the lockdown implemented to contain it, investors have put a hold on their investments and took a wait-and-watch approach to assess the situation. Even the top private equity firms in India are abstaining from making heavy investments in the current situation due to fear of probable loss.

However, due to the COVID-19 pandemic, focus on the healthcare sector and investment opportunities in hospitals, pharmaceuticals, diagnostic, and health tech have increased manifolds. Healthcare companies are investing heavily and Quadria Capital, one of the top private equity firms in Singapore and Asia Pacific reason is providing funds for companies to innovate new and world-class healthcare services.

It is also true that fundraising and investment will take a toll because of heavy reliance on Chinese venture capital firms. Restrictions imposed on international travel will also be one factor among less investment. However, many investment opportunities will come up despite economic slowdown. Sectors such as healthcare, fintech, IT/ITes, etc. are will provide better investment opportunities for investors. Hence, we can say not all is lost due to the current pandemic and the world economy will recover over time.

Comments

Popular posts from this blog

Private Equity’s Role in Tackling Global Healthcare Inequalities

The Effect of Private Equity Investment in Asia’s Health Care Sector

Private Equity Firms in India Drive Growth in Healthcare & MedTech